Brain imaging research uses advanced scanning methods to observe brain structure, function and chemistry in living people. Techniques such as MRI and fMRI measure brain anatomy and blood oxygenation, allowing researchers to see which regions become active during tasks like language, memory or decision making. Diffusion MRI tracks the movement of water along white matter tracts, revealing the brain’s wiring and how regions communicate.

Positron emission tomography and other molecular imaging tools detect specific chemicals, receptors or proteins. These methods are crucial in studying neurodegenerative diseases, because they can visualize abnormal protein deposits and changes in neurotransmitter systems years before symptoms become severe. Structural imaging reveals patterns of brain atrophy, while functional imaging detects disrupted network activity, helping differentiate between types of dementia and monitor progression.

In psychiatry, brain imaging identifies altered connectivity and activity patterns linked to conditions such as depression, schizophrenia and anxiety. It supports the idea that mental disorders arise from circuit level dysfunctions rather than isolated lesions. Multimodal approaches that combine structural, functional and molecular data aim to build more complete models of brain organization.

Large scale projects now collect brain scans alongside genetic, behavioral and clinical data, enabling researchers to map how individual differences in brain wiring relate to cognition and risk for disease. Machine learning methods analyze these complex datasets to detect subtle patterns that might predict diagnosis, prognosis or treatment response. Although brain imaging is not yet a standalone diagnostic tool for most conditions, it is transforming understanding of how the healthy and diseased brain works and guiding the development of more targeted therapies.